|
|||||
|
|
Technical solutions to improve the management of non‐muscle‐invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro‐Technology (ESUT) and Section for Uro‐Oncology (ESOU) expert meeting and current and future perspectives |
|
| Authors: | Thorsten Bach Rolf Muschter Thomas R.W. Herrmann Thomas Knoll Cesare M. Scoffone M. Pilar Laguna Andreas Skolarikos Pascal Rischmann Günter Janetschek Jean J.M.C.H. De la Rosette Udo Nagele Bernard Malavaud Alberto Breda Juan Palou Alexander Bachmann Thomas Frede Petrisor Geavlete Evangelos Liatsikos Patrice Jichlinski Hartwig E. Schwaibold Piotr Chlosta Alexey G. Martov Alberto Lapini Joerg Schmidbauer Bob Djavan Arnulf Stenzl Mauricio Brausi Jens J. Rassweiler |
| Affiliation: | 1. Department of Urology, Asklepios Hospital Harburg, Hamburg, Germany;2. Department of Urology, Diakoniekrankenhaus Rotenburg, Rotenburg, Germany;3. Department of Urology, MHH Medical School of Hannover, Hannover, Germany;4. Department of Urology, Klinikum Sindelfingen‐B?blingen, Sindelfingen, Germany;5. Department of Urology, Cottolengo Hospital, Torino, Italy;6. Department of Urology, AMC University of Amsterdam, Amsterdam, The Netherlands;7. Second Department of Urology, Sismanoglio Hospital, Athens Medical School, Athens, Greece;8. Department of Urology, Rangueil University Hospital, Toulouse, France;9. Department of Urology, Paracelsius Medical University, Salzburg, Austria;10. Department of Urology, LKH Hall, Hall in Tirol, Austria;11. Department of Urology, Fundacio Puigvert, Autonoma University of Barcelona, Barcelona, Spain;12. Department of Urology, University Hospital Basel, Basel, Switzerland;13. Department of Urology, Helios Klinik Müllheim, Müllheim, Germany;14. Department of Urology, Saint John Emergency Clinical Hospital, Bucharest, Romania;15. Department of Urology, University of Patras, Patras, Greece;16. Department of Urology, CHUV, Lausanne, Switzerland;17. Department of Urology, Kreiskliniken Reutlingen, Reutlingen, Germany;18. Department of Urology, Centre of Oncology, Kielce, Poland;19. Department of Endourology, Municipal Clinical Hospital #57 of Moscow, Moscow, Russian Federation;20. Department of Urology, Careggi Hospital, University of Florence, Florence, Italy;21. Department of Urology, Medical University of Vienna, Vienna, Austria;22. Department of Urology, University of Tübingen, Tübingen, Germany;23. Department of Urology, New Estense S. Agostino Hospital Ausl Modena, Modena, Italy;24. Department of Urology, Klinikum Heilbronn, Heilbronn, Germany |
| Abstract: | The aim of the present review was to compare state‐of‐the‐art care and future perspectives for the detection and treatment of non‐muscle‐invasive transitional cell carcinoma (TCC) of the bladder. We provide a summary of the third expert meeting on ‘Optimising the management of non‐muscle‐invasive bladder cancer, organized by the European Association of Urology Section for Uro‐Technology (ESUT) in collaboration with the Section for Uro‐Oncology (ESOU), including a systematic literature review. The article includes a detailed discussion on the current and future perspectives for TCC, including photodynamic diagnosis, optical coherence tomography, narrow band imaging, the Storz Professional Image Enhancement system, magnification and high definition techniques. We also provide a detailed discussion of future surgical treatment options, including en bloc resection and tumour enucleation. Intensive research has been conducted to improve tumour detection and there are promising future perspectives, that require proven clinical efficacy. En bloc resection of bladder tumours may be advantageous, but is currently considered to be experimental. |
| Keywords: | bladder cancer photodynamic diagnosis narrow band imaging optical coherence tomography Storz Professional Image Enhancement system transurethral resection of the bladder en bloc resection |